Subscribe For More!

Receive the latest news from MVI Pharma

You have been successfully Subscribed! Ops! Something went wrong, please try again.
Edit Template

Welcome to your go-to resource for the latest insights, knowledge, and updates on visual inspection of injectable products. In an industry where patient safety is paramount, ensuring that injectable products are free of visible particulates and other defect conditions is not just a goal—it’s a responsibility. With a wealth of experience and a commitment to continuous improvement, our team is here to share what we’ve learned and help push the pharmaceutical industry forward.

“Our mission is simple yet profound: to enhance the understanding and application of visual inspection processes and particulate control in the pharmaceutical industry.”

We aim to equip professionals with the knowledge needed to implement a holistic, risk-based approach to visible particulate control. By sharing our collective expertise, we hope to decrease the number of FDA recalls due to visible particulate contamination. We believe that by educating those in key decision-making positions, we can drive significant improvements in visual inspection programs, thereby ensuring the safety, efficacy, and quality of injectable products for patients worldwide.

Why Visual Inspection Matters

Visible particulates in injectable products are not just a regulatory concern—they are a direct threat to patient safety. When a visible particulate is detected in an injectable drug, it raises concerns about the product’s sterility, integrity, and overall quality. Contaminated injectables can lead to severe adverse reactions, including infections, emboli, and even death. That’s why our focus on this critical area is unwavering. We are committed to sharing comprehensive knowledge, best practices, and practical solutions to help pharmaceutical companies minimize the risk of particulate contamination.

What We Offer

Our blog serves as a comprehensive guide for those involved in the quality assurance, quality control, and manufacturing of injectable products. We delve into a wide array of topics, including:

  • Visual Inspection Methodologies: Learn about different methods, techniques, and strategies for effective visual inspection, including manual, semi-automated, and fully automated inspection processes.

  • Inspector Training and Qualification: Understand the importance of properly training and qualifying inspectors, the cornerstone of any visual inspection program. We provide tips and best practices on creating a robust training program that ensures consistency and reliability.

  • Visual Inspection Stations: From manual to automated systems, we discuss the setup, optimization, and maintenance of visual inspection stations to ensure maximum defect detection efficiency.

  • Deviation and CAPA Management: We explore effective management of deviations and Corrective and Preventive Actions (CAPAs) to address issues related to visual inspection and particulate control.

  • Patient Safety and Risk Management: Discover how to assess and mitigate risks associated with visible particulates to protect patient safety and maintain compliance with regulatory standards.

  • Data Trending and Monitoring: Learn how to leverage data for continuous improvement, from trending defect rates to analyzing inspection data for meaningful insights.

  • Regulatory Standards, Guidances, and Best Practices: Stay up-to-date with the latest regulations, industry standards, and best practices from the FDA, EMA, and other regulatory bodies. We’ll provide insights on how to properly implement and document these changes as part of a robust quality system.

  • FDA Recalls and 483s: We share news and analysis on recent FDA recalls and Form 483 observations related to visible particulates. Learn from these real-world examples to better understand how to mitigate risks and avoid similar pitfalls.

Questions?

Let's Get In Touch!

Subscribe For More!

Get the latest news from MVI Pharma

You have been successfully Subscribed! Ops! Something went wrong, please try again.

Sign up for our newsletter to receive the latest findings, updates, and exclusive content delivered directly to your inbox regularly. Don’t miss out on valuable information that can keep you up-to-date and engaged with our ongoing mission!

Top News

Sponsored News

Bulk Package

Subscriptions

Customer Support

Worldwide Politics

Services

Sponsored News

Bulk Package

Subscriptions

Customer Support

Worldwide Politics

Company

Sponsored News

Bulk Package

Subscriptions

Customer Support

Worldwide Politics

Subscribe For More!

Get the latest news from MVI Pharma

You have been successfully Subscribed! Oops! Something went wrong, please try again.

Sign up for our newsletter to receive the latest findings, updates, and exclusive content delivered directly to your inbox regularly. Don’t miss out on valuable information that can keep you up-to-date and engaged with our ongoing mission!

© 2024 MVI Pharma